Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation
Article in Molecular Cancer (April 2024)
The most recent citing publications are shown below. View all 221 publications that cite this research output on Dimensions.
Unconventional strategy could be the future: from target to KRAS broad range treatment.
Article in Heliyon (April 2024)
Emerging Therapies in Kirsten Rat Sarcoma Virus (+) Non-Small-Cell Lung Cancer
Article in Cancers (April 2024)